These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36993427)

  • 1. Cardiovascular disease and type 2 diabetes in older adults: a combined protocol for an individual participant data analysis for risk prediction and a network meta-analysis of novel anti-diabetic drugs.
    Ribero VA; Alwan H; Efthimiou O; Abolhassani N; Bauer DC; Henrard S; Christiaens A; Waeber G; Rodondi N; Gencer B; Del Giovane C
    medRxiv; 2023 Mar; ():. PubMed ID: 36993427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a life expectancy estimator for multimorbid older adults: a cohort study protocol.
    Gastens V; Del Giovane C; Anker D; Feller M; Syrogiannouli L; Schwab N; Bauer DC; Rodondi N; Chiolero A
    BMJ Open; 2021 Aug; 11(8):e048168. PubMed ID: 34433596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models.
    Akyea RK; Leonardi-Bee J; Asselbergs FW; Patel RS; Durrington P; Wierzbicki AS; Ibiwoye OH; Kai J; Qureshi N; Weng SF
    BMJ Open; 2020 Jul; 10(7):e034564. PubMed ID: 32718921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy weight-loss interventions to prevent type 2 diabetes in overweight or obese adults and older adults: A protocol for systematic review and network meta-analysis.
    Yang W; Wen J; Wu F; Zeng H; Guo B; Ge L
    Medicine (Baltimore); 2021 Mar; 100(11):e24812. PubMed ID: 33725948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.
    Kanie T; Mizuno A; Takaoka Y; Suzuki T; Yoneoka D; Nishikawa Y; Tam WWS; Morze J; Rynkiewicz A; Xin Y; Wu O; Providencia R; Kwong JS
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013650. PubMed ID: 34693515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
    Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
    BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Disease Population Risk Tool (CVDPoRT): predictive algorithm for assessing CVD risk in the community setting. A study protocol.
    Taljaard M; Tuna M; Bennett C; Perez R; Rosella L; Tu JV; Sanmartin C; Hennessy D; Tanuseputro P; Lebenbaum M; Manuel DG
    BMJ Open; 2014 Oct; 4(10):e006701. PubMed ID: 25341454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial).
    Jürgens M; Schou M; Hasbak P; Kjær A; Wolsk E; Zerahn B; Wiberg M; Brandt NH; Gæde PH; Rossing P; Faber J; Inzucchi S; Gustafsson F; Kistorp CM
    BMJ Open; 2019 Nov; 9(11):e029098. PubMed ID: 31780586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for the WARM Hearts study: examining cardiovascular disease risk in middle-aged and older women - a prospective, observational cohort study.
    Rose AV; Boreskie KF; Hay JL; Thompson L; Arora RC; Duhamel TA
    BMJ Open; 2021 May; 11(5):e044227. PubMed ID: 34035097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.
    Wright AK; Suarez-Ortegon MF; Read SH; Kontopantelis E; Buchan I; Emsley R; Sattar N; Ashcroft DM; Wild SH; Rutter MK
    Circulation; 2020 Nov; 142(20):1925-1936. PubMed ID: 33196309
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.